Search Results
Nov 25, 2025, 08:31 ET Nagoya Institute of Technology Researchers Propose Novel BaTiO3-Based Catalyst for Oxidative Coupling of Methane
cost-effectiveness, and mature industrial-scale production technology.In a recent breakthrough, a team of researchers led by Mr. Rongguang Gan, a PhD student from Nagoya Institute of Technology (NITech), Japan, along with Dr. Yoshihide Nishida and Prof. Dr. Tomokatsu Hayakawa from NITech, and Mr. Andreas
More news about: Nagoya Institute of Technology
Nov 25, 2025, 08:15 ET Akston Initiates Clinical Trial of Once-Weekly GLP-1 Weight-Management Therapy for Cats
duration of action."Feline obesity is one of the most common yet least effectively treated health issues in veterinary medicine," said Todd Zion, PhD, co-founder and chief executive officer of Akston. "By advancing a once-weekly GLP-1 therapy, we're addressing a real unmet need and aiming
More news about: Akston
Nov 25, 2025, 06:00 ET Business Psychologist Dr. Melonie Boone Relaunches Boone Management Group, a Management Consulting Firm
Complete Concepts to BMG. Five years later, Dr. Boone pivoted to other related pursuits, including motherhood, opening a publishing house, pursuing her PhD in business psychology, and authoring a
More news about: Boone Management Group
Nov 24, 2025, 19:01 ET UT Health San Antonio scientists launch innovative therapy study to help Parkinson's patients swallow safely
malnutrition, aspiration and reduced quality of life. With a new three-year, $1.9 million grant from the Department of Defense, Giselle Carnaby, PhD, MPH, a researcher at
More news about: UT Health San Antonio
Nov 24, 2025, 17:56 ET Novartis receives FDA approval for Itvisma®, the only gene replacement therapy for children two years and older, teens, and adults with spinal muscular atrophy (SMA)
abeparvovec is a game-changing advance, expanding the use of transformational gene replacement therapy for SMA across age groups," said John W. Day, MD, PhD, Professor of Neurology and Pediatrics, Director, Division of Neuromuscular Medicine at Stanford University School of Medicine, and Co-Director of Stanford's
More news about: Novartis
Nov 24, 2025, 15:52 ET One in two people in the U.S. is affected by a neurological disease or disorder
neurodevelopmental disorders account for a disproportionate share of disability, illness and death across the United States," said author Jaimie Steinmetz, PhD, MSc, of the Institute for Health Metrics and Evaluation at the University of Washington in Seattle. "Our analysis, the most comprehensive assessment
More news about: American Academy of Neurology
Nov 24, 2025, 10:52 ET Readout of Phase 3 Semaglutide Trials Marks Critical Moment in Alzheimer's Research and Suggests Potential for Combination Therapies
in 2011 in a pioneering phase 2 study of liraglutide – an early generation injectable GLP-1 medication – conducted by Paul Edison, MBBS, PhD, FRCPI, Professor of Neuroscience in the Faculty of Medicine at Imperial College London. This early investment not only advanced understanding of GLP-1
More news about: Alzheimer's Drug Discovery Foundation
Nov 24, 2025, 10:47 ET Cordance Medical Announces an Oversubscribed $8M Seed Financing to Advance Focused Ultrasound Platform for Brain Disease Treatment
team is thrilled to announce this financing round and is grateful to all our investors for their confidence in our mission," said Bhaskar Ramamurthy, PhD, Co-founder and CEO of Cordance Medical. "Alongside our academic collaborators and industry partners, this strong syndicate backing reflects the urgent
More news about: Cordance Medical
Nov 24, 2025, 10:00 ET GEMMABio Announces Clinical Trial Authorization for New SMA1 Gene Therapy
Brazil. The promising preclinical data from GEMMABio's first clinical-stage program was presented by the company's President and CEO, James M. Wilson, MD, PhD, at the INAME 2025 Spinal Muscular Atrophy Congress which took place on November 21-23, 2025, in São Paulo, Brazil.
More news about: GEMMA Biotherapeutics
Nov 24, 2025, 09:00 ET American Nurses Foundation Announces Mini-Grant Recipients for Expanding Nurse Well-Being Program into Rural or Long-Term Care Settings
Health) in Bennington, VT. Principal Investigator: Alison Camarda, PhD, RN, NPD-BC, CEN, CPEN, SANEWesley Pines Retirement Community (with Fayetteville State University) in Lumberton, NC. Principal Investigators: Misty Stone, PhD, RN and Stephanie Hodges DNP, FNP-C, CNEclProvidence Centralia
More news about: American Nurses Foundation
Nov 24, 2025, 09:00 ET Circular Genomics to Unveil New Data Highlighting Circular RNAs as a Transformative New Class of Blood-Based Biomarkers for Alzheimer's Disease at CTAD 2025
disease continuum representing a transformative pathway to significant improvements over existing standard-of-care methods ", said Nikolaos Mellios, MD, PhD, Chief Scientific Officer and co-founder of Circular Genomics. "Circular RNAs are brain-derived, highly stable, and measurable biomarkers in blood, providing
More news about: Circular Genomics
Nov 24, 2025, 08:30 ET CENTURY LITHIUM REPORTS LATEST DEVELOPMENTS AT ANGEL ISLAND LITHIUM PROJECT, NEVADA
centurylithium.com. ON BEHALF OF CENTURY LITHIUM CORP.WILLIAM WILLOUGHBY, PhD., PEPresident & Chief Executive Officer
More news about: Century Lithium Corp.
Nov 24, 2025, 08:00 ET DarioHealth Announces Publication of Sanofi Study in JMIR Demonstrating an Estimated $5,077 Medical Cost Savings Per Dario Digital Health Platform User Per Year
care."Real-world economic validation from peer-reviewed research is critical for organizations evaluating digital health solutions," said Yifat Hershcovitz, PhD, Vice President of Clinical and Scientific Affairs at Dario. "This study shows that when members engage with Dario's connected devices, personalized
More news about: DarioHealth Corp.
Nov 24, 2025, 05:19 ET Drs. Elliott Brea, Esther Redin, and Gavitt Woodard Announced as Recipients of LUNGevity's Career Development Awards
mentorship opportunities and receive training in effective science communications."Today's research is tomorrow's cure," said Upal Basu Roy, PhD, MPH, Executive Director of LUNGevity Research. "If we want to see continued breakthroughs and advancements in lung cancer, we must secure a strong pipeline
More news about: LUNGevity Foundation
Nov 24, 2025, 05:18 ET Salimetrics Launches 'Tools for Your Toolbox' to Improve Research Study Management
decisions define the integrity, reproducibility, and translational value of research long before the first sample is ever collected," says Douglas Granger, PhD, Salimetrics Chief Science and Strategy Advisor. "If you've ever thought that there must be an easier way to do this, there is. We have the right tool
More news about: Salimetrics, LLC
Nov 24, 2025, 04:24 ET HoneyNaps Accelerates Clinical Trial Pipelines with FDA-Cleared AI "SOMNUM"
evaluating the effectiveness of CPAP devices, sleep sensors, wearable devices, and a range of sleep-technology products.Taekyoung (Sean) Ha, PhD, President of HoneyNaps USA, stated, "SOMNUM's PSG AI scoring technology is fundamentally transforming the traditionally time-consuming manual scoring
More news about: HoneyNaps
Nov 24, 2025, 03:31 ET Dr James Liang Launches HK$500 Million "Genovation Foundation" to Address Low Fertility
2026 and held annually thereafter, the foundation has opened applications in two further areas:Childbearing subsidies for PhD students in Hong KongGrants for fertility-friendly cultural and artistic projects worldwideAs a scholar-entrepreneur
More news about: The Genovation Foundation
Nov 23, 2025, 09:00 ET rScriptor Enhances Radiology Workflow With Flexible AI Impression Generation
"Generative AI as it exists in other radiology reporting applications is a black box," said John Stewart, MD, PhD, Founder and CEO of Scriptor Software. "These AI algorithms produce a single result that the radiologist has little or no control over. We have taken
More news about: Scriptor Software
Nov 21, 2025, 13:30 ET Researchers Highlight Genetic Factors in Pediatric Brain and Spinal Cord Tumors
Sharon J. Diskin, PhD, senior author of the study and principal investigator at CHOP's
More news about: Children's Hospital of Philadelphia
Nov 21, 2025, 09:00 ET Sorcero Secures $42.5M Series B Financing Led by NewSpring Capital to Scale Its AI Platform, Accelerate Expansion Across Life Sciences
Medically-tuned AI agents ingest, analyze, and validate information to ensure 96.1% clinical inclusion accuracy, surpassing the 95% FDA regulatory threshold and PhD-level human performance.Unlike traditional medical outreach informed primarily by U.S.-only claims data and prescription volumes, Sorcero reads
More news about: Sorcero
Nov 21, 2025, 08:30 ET Caris Precision Oncology Alliance Fellows Forum Welcomes 2025/2026 Class
of Miami Miller School of MedicineJanina Pearce, MD, PhD, Women and Infants Hospital/Brown University Natalie Reed, DO, PGY-4, Hematology Oncology fellow, Atrium Health Levine CancerRyan Michael Reyes, MD, PhD, Washington University School of Medicine in St. LouisKelsey
More news about: Caris Life Sciences
Nov 21, 2025, 08:04 ET SK Life Science, Inc. to Present 10 Posters with New Cenobamate Data, Including a Late-Breaker, at the 2025 American Epilepsy Society (AES) Annual Meeting
Meeting is a vital forum to share the latest science that can make a real difference in the lives of people living with epilepsy," said Sunita Misra, MD, PhD, Vice President of Global Clinical Development and Chief Medical Officer, SK Life Science, Inc. "We are proud to present new data on cenobamate that
More news about: SK Life Science, Inc.
Nov 21, 2025, 06:22 ET Weekly Recap: 14 Health Press Releases You Need to See
others, and connection is what the holidays are all about," says American Speech-Language-Hearing Association 2025 President Bernadette Mayfield-Clarke, PhD, CCC-SLP. "By modifying how you approach a loved one who is dealing with the disease, family and friends can communicate more effectively and have more
More news about: PR Newswire
Nov 20, 2025, 17:00 ET Dr. Lisa Su, AMD Chair and CEO, Elected Chair of Semiconductor Industry Association
to her roles at AMD, Dr. Su held leadership roles with Freescale Semiconductor (now NXP Semiconductors), IBM, and Texas Instruments. Dr. Su holds a PhD in electrical engineering from the Massachusetts Institute of Technology, and in 2020 received the
More news about: Semiconductor Industry Association
Nov 20, 2025, 14:55 ET How Evf2 lncRNA Advances Research in Brain and Neurodevelopmental Disorders, Upcoming Webinar Hosted by Xtalks
reshaping neuroscience research and revealing new opportunities in functional genomics. Join Jhumku Kohtz, PhD, Professor in Neurology, Feinberg School of Medicine, Northwestern University; and Ibrahim Jivanjee, AVP and GM, Discovery Business,
More news about: Xtalks